Current and Emerging Treatment for Diabetic Macular Edema.
Publication
, Journal Article
Ung, C; Borkar, DS; Young, LH
Published in: Int Ophthalmol Clin
2017
Duke Scholars
Published In
Int Ophthalmol Clin
DOI
EISSN
1536-9617
Publication Date
2017
Volume
57
Issue
4
Start / End Page
165 / 177
Location
United States
Related Subject Headings
- rho-Associated Kinases
- Vascular Endothelial Growth Factor A
- Receptor, TIE-2
- Protein Kinase Inhibitors
- Ophthalmology & Optometry
- Molecular Targeted Therapy
- Macular Edema
- Integrins
- Humans
- Diabetic Retinopathy
Citation
APA
Chicago
ICMJE
MLA
NLM
Ung, C., Borkar, D. S., & Young, L. H. (2017). Current and Emerging Treatment for Diabetic Macular Edema. Int Ophthalmol Clin, 57(4), 165–177. https://doi.org/10.1097/IIO.0000000000000191
Ung, Cindy, Durga S. Borkar, and Lucy H. Young. “Current and Emerging Treatment for Diabetic Macular Edema.” Int Ophthalmol Clin 57, no. 4 (2017): 165–77. https://doi.org/10.1097/IIO.0000000000000191.
Ung C, Borkar DS, Young LH. Current and Emerging Treatment for Diabetic Macular Edema. Int Ophthalmol Clin. 2017;57(4):165–77.
Ung, Cindy, et al. “Current and Emerging Treatment for Diabetic Macular Edema.” Int Ophthalmol Clin, vol. 57, no. 4, 2017, pp. 165–77. Pubmed, doi:10.1097/IIO.0000000000000191.
Ung C, Borkar DS, Young LH. Current and Emerging Treatment for Diabetic Macular Edema. Int Ophthalmol Clin. 2017;57(4):165–177.
Published In
Int Ophthalmol Clin
DOI
EISSN
1536-9617
Publication Date
2017
Volume
57
Issue
4
Start / End Page
165 / 177
Location
United States
Related Subject Headings
- rho-Associated Kinases
- Vascular Endothelial Growth Factor A
- Receptor, TIE-2
- Protein Kinase Inhibitors
- Ophthalmology & Optometry
- Molecular Targeted Therapy
- Macular Edema
- Integrins
- Humans
- Diabetic Retinopathy